10-Q: Minerals Technologies Reports Q2 Profit Amidst Overall Half-Year Loss Driven by Talc Litigation Reserve

Minerals Technologies Inc. reported a net income of $45.4 million for Q2 2025, a significant improvement from the prior year, but recorded a net loss of $98.6 million for the first six months of 2025 primarily due to a $215 million litigation reserve for talc-related claims.

Summary

• Net sales for Q2 2025 decreased 2% to $528.9 million from $541.2 million in Q2 2024.
• Net sales for the first six months of 2025 decreased 5% to $1,020.7 million from $1,075.7 million in the prior year period.
• Net income attributable to Minerals Technologies Inc. for Q2 2025 was $45.4 million ($1.44 diluted EPS), up from $19.7 million ($0.61 diluted EPS) in Q2 2024.
• Net loss attributable to Minerals Technologies Inc. for the first six months of 2025 was $98.6 million ($-3.11 diluted EPS), compared to net income of $66.4 million ($2.05 diluted EPS) in the prior year period.
• The six-month net loss was primarily driven by a $215 million provision for litigation reserve and credit losses related to talc claims, recorded in Q1 2025.
• Operating income for Q2 2025 increased to $74.6 million from $50.6 million in Q2 2024, benefiting from a $5.6 million gain on asset sale and lower prior-year credit loss provision.
• Operating loss for the first six months of 2025 was $85.5 million, compared to income of $125.8 million in the prior year period, largely due to the $215 million litigation provision.
• The company repurchased $19.1 million in shares in Q2 2025 under its $200 million buyback program.
• Cash and cash equivalents were $313.8 million as of June 29, 2025, with over $650 million in available liquidity.
• Restructuring charges of $5.8 million in Q2 2025 and $11.3 million for the six-month period were recorded for facility consolidation and workforce reductions.

Sentiment

Score: 3

Explanation: The significant net loss for the first half of the year, driven by a large litigation reserve, overshadows the improved Q2 net income. While Q2 showed some operational improvements and strong liquidity, the ongoing, substantial talc litigation and declining sales in key segments present considerable headwinds and uncertainty. The future financial impact of the litigation remains unquantifiable beyond the accrued amount, indicating significant unresolved risk.

Positives

• Net income attributable to Minerals Technologies Inc. for Q2 2025 significantly increased to $45.4 million from $19.7 million in Q2 2024.
• Diluted earnings per share for Q2 2025 rose to $1.44 from $0.61 in Q2 2024.
• Income from operations for Q2 2025 improved to $74.6 million from $50.6 million in Q2 2024.
• A $5.6 million net gain was realized on the final installment for the sale of refractories manufacturing assets in China.
• The company repurchased $19.1 million in shares in Q2 2025, demonstrating commitment to shareholder returns.
• Strong liquidity position with $319.9 million in cash, cash equivalents, and short-term investments, and over $650 million in available liquidity as of June 29, 2025.
• Interest expense, net, decreased to $13.6 million in Q2 2025 from $14.9 million in Q2 2024, and to $27.8 million for the six months from $29.8 million in the prior year.
• The company is in compliance with all debt covenants under the Amended Credit Agreement.

Negatives

• Net loss attributable to Minerals Technologies Inc. for the first six months of 2025 was $98.6 million, a significant decline from net income of $66.4 million in the prior year period.
• A substantial $215 million provision for litigation reserve and credit losses was recorded in Q1 2025 for talc-related claims and Chapter 11 funding.
• Total net sales decreased 2% in Q2 2025 to $528.9 million and 5% for the six-month period to $1,020.7 million.
• Production margin decreased to 25.9% of sales in Q2 2025 from 26.6% in Q2 2024, and to 25.1% for the six-month period from 26.0% in the prior year.
• Sales in the Consumer & Specialties segment decreased 2% in Q2 and 6% for the six-month period, driven by weaker paper demand in North America and Europe, and customer inventory destocking.
• Sales in the Engineered Solutions segment decreased 2% in Q2 and 4% for the six-month period, primarily due to weaker demand in Europe for High-Temperature Technologies and lower sales in offshore water filtration for Environmental & Infrastructure.
• Restructuring and other items charges totaled $5.8 million in Q2 2025 and $11.3 million for the six-month period due to facility consolidation and workforce reductions.
• Litigation expenses related to Oldco's bankruptcy were $4.2 million in Q2 2025 and $7.0 million for the six-month period.

Risks

• Worldwide general economic, business, and industry conditions may adversely affect results, including declining consumer and business confidence, volatile raw material prices, instability in credit markets, high unemployment, and fluctuating interest and exchange rates.
• Cyclicality of customer businesses (metalcasting, steel, paper, construction, oil & gas) and changing regional demands can reduce product demand and affect financial performance.
• Intense competition, including from lower-cost production countries, could reduce profit margins.
• Consolidation in customer industries (paper, foundry, steel) concentrates purchasing power, increasing pressure on suppliers.
• Failure to renew or extend long-term sales contracts for satellite operations could substantially affect results and lead to asset impairment.
• Servicing debt requires significant cash, which could reduce flexibility to respond to changing business conditions or fund capital expenditures/working capital needs.
• Debt agreements contain covenants (e.g., maximum Net Leverage Ratio of 4.00 to 1.00) that limit operational flexibility; a breach could lead to default.
• Inability to effectively achieve and implement growth initiatives, including geographic expansion and acquisitions, could adversely affect future growth.
• Delays or failures in new product development, testing, production, marketing, or sale could cause results to differ from expectations.
• Inability to defend intellectual property against inappropriate disclosure, theft, and infringement, or development of more effective/less expensive competitor products, could harm financial condition.
• Increased risks of doing business abroad, including inflation, fluctuating interest rates, changes in laws, nationalization, expropriation, limits on fund repatriation, civil unrest, unstable governments, and trade restrictions (tariffs).
• Dependence on raw material availability (lime, carbon dioxide, magnesia, alumina) and access to ore reserves; price increases for raw materials, energy, or shipping could adversely affect financial results.
• Production facilities are subject to operating risks and capacity limitations, including hazards (leaks, explosions, fires, mechanical failure), unscheduled downtime, labor difficulties, transportation interruptions, and governmental requirements.
• Seasonality of certain businesses (energy services, construction, specialty additives) due to weather patterns can lead to volatile demand.
• Cyber-attacks and other disruptions to information systems could interrupt business operations, lead to loss/damage of intellectual property or data, and increase costs.
• Uncertainty regarding the ultimate amount necessary to be contributed to any trust established for talc-related claims under Section 524(g) of the U.S. Bankruptcy Code.
• Potential for talc-related exposure to extend beyond the Chapter 11 Debtors (Oldco and BVT) due to claims by talc plaintiffs, corporate veil piercing efforts, or the scope of Pfizer indemnity.
• Ongoing costs and length of time necessary to resolve the Chapter 11 Cases.
• Inability to predict how the District Court will rule on pending motions or whether an appellate court will affirm or reverse the Bankruptcy Court order denying the Committee's motion to dismiss.
• Risk that the Chapter 11 Debtors will be unsuccessful in attaining relief under Chapter 11.
• Potential for significant payments from settlements or judgments in excess of accrued liabilities if the automatic stay is lifted or exceptions apply.
• Unanticipated costs or liabilities from legal, environmental, and tax matters or product stewardship issues, including changes to laws/regulations, enforcement policies, or further investigation of environmental/health hazards.
• Impact of climate-related legislation or regulation restricting greenhouse gas emissions on operations or product demand.

Future Outlook

The company will continue to focus on innovation and new product development, and other opportunities for sales growth in 2025 from its existing businesses. This includes increasing market share in global pet litter, deploying new pet care products, expanding calcium carbonate sales in paper and packaging, promoting crystal engineering, developing new products for paint/coating/packaging, pursuing waste management and recycling opportunities, developing bleaching earth products for edible oil/renewable fuel, creating new mineral-based solutions for personal care, increasing retinol delivery technology presence, expanding bentonite solutions for animal health, and increasing fabric care market share. For Engineered Solutions, the outlook includes increasing bentonite-based foundry solutions in emerging markets, deploying value-added refractory formulations, expanding laser measurement technologies, extending refractory maintenance models, continuing development of FLUORO-SORB for PFAS contamination, and pursuing expanded use of products in environmental, building, construction, infrastructure, and oil & gas drilling/water treatment globally, and increasing geosynthetic clay liner market share. Across all segments, the company aims for further operational excellence and exploring selective acquisitions. The company is monitoring the economic effects of new tariffs and implementing mitigation plans, but effects remain uncertain.

Management Comments

• Our balance sheet continues to be strong.
• We believe that these factors will allow us to meet our anticipated funding requirements.
• The Company continues to monitor the economic effects of such announcements [tariffs] and is implementing plans to mitigate their related impacts, but the effects associated with the tariffs remain uncertain.
• The Company will continue to focus on innovation and new product development and other opportunities for sales growth in 2025 from its existing businesses.
• The Company supports this path forward [Bankruptcy Court's Report and Recommendation].
• The Company's position, as stated publicly, is that the talc products sold by Oldco are safe and do not cause cancer.
• Although the Company believes that the talc products are safe and that claims to the contrary are without merit, Oldco opportunistically settled certain talc-related cases in 2022 and 2023.
• The Company is in compliance with all the covenants contained in the Amended Credit Agreement throughout the period covered by this report.

Industry Context

The company operates in cyclical industries like metalcasting, steel, and paper, which are sensitive to economic fluctuations. The paper industry, a key market for the Consumer & Specialties segment, is experiencing declining production levels in North America and Europe. The Environmental & Infrastructure segment is affected by commercial construction, infrastructure, and oil & gas markets. The company is diversifying into less cyclical consumer-oriented markets (pet litter, personal care, oil purification) and expanding geographically into emerging markets (Brazil, India, China, Middle East, Eastern Europe) to mitigate these cyclical risks. New tariffs and geopolitical instability are noted as broader industry challenges.

Legal Proceedings

• The company is a party to numerous lawsuits arising in the normal course of business.
• The most significant litigation involves over 700 open cases related to alleged exposure to asbestos-contaminated talc products previously sold by BMI Oldco Inc. (Oldco).
• Oldco and Barretts Ventures Texas LLC (BVT) filed for Chapter 11 bankruptcy on October 2, 2023, to resolve talc liabilities, with the ultimate goal of establishing a trust under Section 524(g) of the U.S. Bankruptcy Code.
• Minerals Technologies Inc. and its other subsidiaries were not included in the Chapter 11 filing.
• A $215 million provision was recorded in Q1 2025 for estimated costs to fund this trust and related Chapter 11/litigation costs, including a $30 million increase to the Debtor-in-Possession (DIP) Credit Agreement.
• The company believes its talc products are safe and claims are without merit, but Oldco settled some cases in 2022 and 2023.
• The Bankruptcy Court temporarily enjoined talc-related claims against non-debtor affiliates, with exceptions for claims based on alleged testing inadequacies.
• Pfizer, which historically bore most talc-related costs due to a 1992 indemnification agreement, filed a motion in May 2024 to sue the company regarding this agreement; mediation is ongoing.
• The Committee representing talc claimants filed a motion to dismiss the Chapter 11 Cases, which was denied by the Bankruptcy Court on April 29, 2025. The Committee is appealing this denial.
• On May 14, 2025, the Bankruptcy Court recommended the District Court determine if Oldco's talc contained sufficient asbestos to cause disease and abated the Chapter 11 Cases pending this determination.
• The company is unable to estimate the possible loss or range of loss beyond the accrued amount due to ongoing uncertainties in the Chapter 11 Cases and potential for new claims or adverse rulings.

Related Party Transactions

• The company entered into a Debtor-in-Possession (DIP) Credit Agreement with its subsidiary, Oldco (a Chapter 11 Debtor), and recorded a $30 million provision for credit loss in Q2 2024.
• In Q2 2025, the company amended the DIP Credit Agreement to increase the maximum principal amount by $30 million, which is included in the $215 million litigation reserve.
• The company is entitled to indemnification from Pfizer Inc. for liabilities arising from sales prior to its 1992 IPO, and Pfizer filed a motion to sue the company related to this agreement, which is now in mediation.

Stakeholder Impact

• Shareholders experienced a significant net loss for the first half of 2025, impacting earnings per share. However, the company continued its share buyback program ($19.1 million in Q2 2025) and declared cash dividends ($0.11 per share in Q2 2025, $0.22 for six months). The ongoing talc litigation poses a significant financial risk.
• Employees are subject to workforce reductions as part of a cost savings program, resulting in severance costs.
• Customers may experience reduced demand due to economic conditions and industry trends (e.g., weaker paper demand). The company is focusing on new product development and market penetration to serve customer needs and expand market share.
• Creditors: The company is in compliance with all debt covenants, indicating financial stability regarding its debt obligations.

Next Steps

• Continue evaluating the full effects of the One Big Beautiful Bill Act on the estimated annual effective tax rate and cash tax position.
• Continue assessing the effect of the Pillar 2 Model Rules in all jurisdictions.
• Pay remaining obligations under workforce reduction initiatives within the next twelve months ($6.7 million as of June 29, 2025).
• Contribute approximately $11.0 million to pension plans and $0.1 million to other post-retirement benefit plans in 2025.
• Continue discussions regarding the terms of a potential consensual plan of reorganization and the ultimate amount to be contributed to any trust for talc-related claims.
• Mediate disputes with Pfizer regarding the 1992 indemnification agreement.
• Continue to focus on innovation and new product development for sales growth in 2025.
• Increase presence and market share in global pet litter products, including emerging markets.
• Deploy new products in pet care such as lightweight litter.
• Increase sales of calcium carbonate products by further penetration into filling and coating applications in paper and packaging markets.
• Promote expertise in crystal engineering by developing crystal morphologies.
• Deploy new calcium carbonate products in paint, coating, and packaging applications.
• Continue developing products and processes for waste management and recycling opportunities.
• Continue to develop innovative applications for bleaching earth products for edible oil and renewable fuel industries.
• Develop new mineral-based solutions for personal care applications.
• Increase presence and market share globally for retinol delivery technology for personal care applications.
• Expand bentonite product solutions for animal health applications.
• Increase presence and market share in fabric care, including emerging markets.
• Increase presence and gain penetration of bentonite-based foundry solutions in emerging markets.
• Deploy value-added formulations of refractory materials.
• Deploy laser measurement technologies into new applications.
• Expand refractory maintenance model to other steel makers globally.
• Continue the development and market penetration of FLUORO-SORB products for PFAS contamination.
• Pursue opportunities for expanded use of products in environmental, building and construction, infrastructure, and oil and gas drilling and water treatment globally.
• Increase presence and market share for geosynthetic clay liners globally.
• Further operational excellence principles into all aspects of the organization.
• Continue to explore selective acquisitions.
• Anticipate capital expenditures of approximately $100 million for 2025.

Key Dates

Recommendation

While the company demonstrated improved Q2 profitability and maintains strong liquidity, the substantial net loss for the first half of 2025, primarily driven by a large $215 million litigation reserve for talc-related claims, introduces significant uncertainty. The ongoing legal proceedings, including the Chapter 11 cases and disputes with Pfizer, present unquantifiable future liabilities that could materially impact financial condition. Declining sales in key segments also indicate demand challenges. Given the mix of operational improvements and significant unresolved legal and market risks, a 'hold' recommendation is appropriate, advising investors to monitor the resolution of the talc litigation and sustained operational performance before making further investment decisions.

Keywords

Specialty Minerals, Industrial Minerals, Talc Litigation, Chemical Products, Engineered Solutions, Consumer & Specialties, Mining, Financial Reporting, SEC Filing, Corporate Debt, Share Buyback, Restructuring, Environmental Solutions, High-Temperature Technologies, Household & Personal Care, Specialty Additives, PFAS, Refractories